Between 33-50% of #TesticularCancer patients are diagnosed with metastatic disease and, despite a high overall survival rate exceeding 95%, survivors frequently grapple with cancer-related fatigue as a prominent concern. ow.ly/CkR350RlCJJ #TesticularCancer AwarenessMonth

Durvalumab and bevacizumab plus TACE is the first immune checkpoint inhibitor-based regimen in a Phase III trial to show statistically significant and clinically meaningful improvement in PFS among patients with unresectable #HCC . Keep reading: ow.ly/TA5V50RmyWB

'Despite [osimertinib] being effective [in #NSCLC ], most if not all patients ultimately at some juncture develop resistance to #osimertinib ,' noted Pasi A. Jänne, MD, PhD. Read how potential additional therapies could prolong the treatment. ow.ly/Gwsv50Rnztp

Challenge your diagnostic skills in this interactive medical case. A 59-year-old woman was hospitalized in April 2019 when she presented with abdominal pain, purpura, and gross hematuria. Can you determine the next step? focusononcology.com/diagnostic-cha… #Oncology #CancerResearch

Tim Rattay, MBChB, PhD, discusses a machine-learning algorithm, PRE-ACT, that predicts post-operative #lymphedema . Listen to the #podcast : ow.ly/Iyfa50Rilxh

Mindy, a 76-year-old retired store owner, was diagnosed with #multiplemyeloma 9 months ago after presenting with back and #neckpain . The patient is concerned about her risk for recurrent infections. What's the next step in her treatment? focusononcology.com/therapeutic-op… #CaseStudy

According to a Friends of Cancer Research briefing paper, about 8% of adult patients with #cancer participate in #clinicaltrials . However, there is often a lack of representation of patients in #minority populations. Read how this can change: ow.ly/3izo50RmfOJ

In a survey of Spanish-speaking sexual minority men, “Only 56% of participants reported having heard about the #HPV vaccine , and responses about #HPV knowledge showed education needs,' said study author Shannon M. Christy, PhD. ow.ly/6HgS50RlgRQ #WorldImmunizationWeek

Osimertinib with platinum-based #chemotherapy has received #FDAapproval for patients with locally advanced or metastatic #NSCLC whose tumors have EGFR exon 19 deletions or exon 21 L858R mutations. ow.ly/rihx50R715M

Heather McArthur, MD, MPH, discusses new data from the Phase III KEYNOTE-756 clinical trial, showing that adding pembrolizumab immunotherapy to #chemotherapy before and after surgery for high-risk #breastcancer resulted in better outcomes: ow.ly/OoRx50Rifqx #podcast

The UK's National Health Service (NHS) has set a goal to increase early #kidneycancer detection rates from 50% to 75% by 2028. Keep reading: ow.ly/Zt8O50Rlo6i #CancerResearch

A study published in the #JNCI saw the largest incidence of #breastcancer among women who had higher #pollution levels near their home, compared to those who lived in areas with lower levels of pollution. ow.ly/fWoB50Rlaxf #CancerResearch

Acute myeloid #leukemia patients who have psychiatric or substance use disorders appear to be at a higher risk of experiencing poorer outcomes following treatment with #venetoclax combinations. Read more: ow.ly/stWo50QUrGs #AML

Data suggests that imaging the tumors of advanced #Melanoma patients undergoing treatment with pembrolizumab after 1 week can identify metabolic changes that are correlated with progression-free survival. Keep reading: ow.ly/jGsm50R8OgG #CancerResearch

Recently published data shed new light on how #diet impacts aging among adult survivors of #childhoodcancer . Read it here: ow.ly/noSe50QXb9U #CancerResearch

Mindy, a 76-year-old retired store owner, was diagnosed with #multiplemyeloma 9 months ago after presenting with back and #neckpain . The patient is concerned about her risk for recurrent infections. What's the next step in her treatment? focusononcology.com/therapeutic-op… #CaseStudy

Oncology Times features #oncologists and #hematologists who have recently earned awards, achievements, and grants. Read this month's Shoptalk: ow.ly/ifk950Rk5fA

Earn #CME and #NCPD credit by completing a quiz about this article. Recent data showed that patients with #NSCLC with an EGFR mutation who underwent first-line treatment with osimertinib plus chemotherapy had significantly longer progression-free survival. ow.ly/bKSj50Rk42H

Challenge your diagnoistic skills in this interactive medical case. A 59-year-old woman was hospitalized in April 2019 when she presented with abdominal pain, purpura, and gross hematuria. Can you determine the next step? focusononcology.com/diagnostic-cha… #Oncology #CancerResearch

A new study published in Nature Medicine assessed genome sequences spanning 5 years of medical records and demonstrated the power of #geneticbiomarkers when used to identify survival odds, optimal therapies, and other oncological factors. ow.ly/b0RT50Rk3Ec #CancerResearch